drugset / Trial / NCT03918798

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

NCT03918798

Phase 2 Completed 164 enrolled Sintetica SA
RandomizedParallel-groupDouble-blindSupportive care

Summary

Randomized, multi-center, double-blind, two-armed, parallel active groups, prospective trial to evaluate the efficacy and safety of local anesthetic Chloroprocaine at two different concentrations ( at 1% and 2%) in a pediatric population subjected to peripheral nerve block due to Inguinal hernia repair or Flat foot surgery. The present Protocol is part of an extensive Pediatric Investigational Plan (PIP) in the contest of the marketing authorization application of chloroprocaine use for perineural block. The PDCO has adopted a positive opinion.

Timeline

Start
2019-02-14
Primary completion
2025-10-17
Completion
2025-10-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 1 % Other
Subject Chloroprocaine Other / unclassified 2 % Other

Indications